These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 27318552)

  • 1. Structural modifications of the serotonin 5-HT7 receptor agonist N-(4-cyanophenylmethyl)-4-(2-biphenyl)-1-piperazinehexanamide (LP-211) to improve in vitro microsomal stability: A case study.
    Lacivita E; Podlewska S; Speranza L; Niso M; Satała G; Perrone R; Perrone-Capano C; Bojarski AJ; Leopoldo M
    Eur J Med Chem; 2016 Sep; 120():363-79. PubMed ID: 27318552
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural modifications of N-(1,2,3,4-tetrahydronaphthalen-1-yl)-4-aryl-1-piperazinehexanamides: influence on lipophilicity and 5-HT7 receptor activity. Part III.
    Leopoldo M; Lacivita E; De Giorgio P; Fracasso C; Guzzetti S; Caccia S; Contino M; Colabufo NA; Berardi F; Perrone R
    J Med Chem; 2008 Sep; 51(18):5813-22. PubMed ID: 18800769
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Towards metabolically stable 5-HT7 receptor ligands: a study on 1-arylpiperazine derivatives and related isosters.
    Lacivita E; De Giorgio P; Patarnello D; Niso M; Colabufo NA; Berardi F; Perrone R; Satala G; Duszynska B; Bojarski AJ; Leopoldo M
    Exp Brain Res; 2013 Oct; 230(4):569-82. PubMed ID: 23571499
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Privileged scaffold-based design to identify a novel drug-like 5-HT
    Lacivita E; Niso M; Stama ML; Arzuaga A; Altamura C; Costa L; Desaphy JF; Ragozzino ME; Ciranna L; Leopoldo M
    Eur J Med Chem; 2020 Aug; 199():112395. PubMed ID: 32442850
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel highly potent serotonin 5-HT7 receptor ligands: structural modifications to improve pharmacokinetic properties.
    Lacivita E; Di Pilato P; Stama ML; Colabufo NA; Berardi F; Perrone R; De Filippis B; Laviola G; Adriani W; Niso M; Leopoldo M
    Bioorg Med Chem Lett; 2013 Nov; 23(22):6083-6. PubMed ID: 24100077
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The arylpiperazine derivatives N-(4-cyanophenylmethyl)-4-(2-diphenyl)-1-piperazinehexanamide and N-benzyl-4-(2-diphenyl)-1-piperazinehexanamide exert a long-lasting inhibition of human serotonin 5-HT7 receptor binding and cAMP signaling.
    Atanes P; Lacivita E; Rodríguez J; Brea J; Burgueño J; Vela JM; Cadavid MI; Loza MI; Leopoldo M; Castro M
    Pharmacol Res Perspect; 2013 Dec; 1(2):e00013. PubMed ID: 25505568
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 1-Aryl-4-(4-succinimidobutyl)piperazines and their conformationally constrained analogues: synthesis, binding to serotonin (5-HT1A, 5-HT2A, 5-HT7), alpha1-adrenergic, and dopaminergic D2 receptors, and in vivo 5-HT1A functional characteristics.
    Bojarski AJ; Paluchowska MH; Duszyńska B; Kłodzińska A; Tatarczyńska E; Chojnacka-Wójcik E
    Bioorg Med Chem; 2005 Mar; 13(6):2293-303. PubMed ID: 15727878
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LP-211 is a brain penetrant selective agonist for the serotonin 5-HT(7) receptor.
    Hedlund PB; Leopoldo M; Caccia S; Sarkisyan G; Fracasso C; Martelli G; Lacivita E; Berardi F; Perrone R
    Neurosci Lett; 2010 Aug; 481(1):12-6. PubMed ID: 20600619
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure-affinity relationship study on N-(1,2,3,4-tetrahydronaphthalen-1-yl)-4-aryl-1-piperazinealkylamides, a new class of 5-hydroxytryptamine7 receptor agents.
    Leopoldo M; Berardi F; Colabufo NA; Contino M; Lacivita E; Niso M; Perrone R; Tortorella V
    J Med Chem; 2004 Dec; 47(26):6616-24. PubMed ID: 15588097
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An Orally Active Phenylaminotetralin-Chemotype Serotonin 5-HT7 and 5-HT1A Receptor Partial Agonist that Corrects Motor Stereotypy in Mouse Models.
    Canal CE; Felsing DE; Liu Y; Zhu W; Wood JT; Perry CK; Vemula R; Booth RG
    ACS Chem Neurosci; 2015 Jul; 6(7):1259-70. PubMed ID: 26011730
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serotonin (5-HT) regulates neurite outgrowth through 5-HT1A and 5-HT7 receptors in cultured hippocampal neurons.
    Rojas PS; Neira D; Muñoz M; Lavandero S; Fiedler JL
    J Neurosci Res; 2014 Aug; 92(8):1000-9. PubMed ID: 24752854
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design, synthesis, radiolabeling and in vivo evaluation of potential positron emission tomography (PET) radioligands for brain imaging of the 5-HT₇ receptor.
    Lacivita E; Niso M; Hansen HD; Di Pilato P; Herth MM; Lehel S; Ettrup A; Montenegro L; Perrone R; Berardi F; Colabufo NA; Leopoldo M; Knudsen GM
    Bioorg Med Chem; 2014 Mar; 22(5):1736-50. PubMed ID: 24508140
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Towards the development of 5-HT₇ ligands combining serotonin-like and arylpiperazine moieties.
    Spadoni G; Bedini A; Bartolucci S; Pala D; Mor M; Riccioni T; Borsini F; Cabri W; Celona D; Marzi M; Tarzia G; Rivara S; Minetti P
    Eur J Med Chem; 2014 Jun; 80():8-35. PubMed ID: 24763360
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aryl biphenyl-3-ylmethylpiperazines as 5-HT7 receptor antagonists.
    Kim J; Kim Y; Tae J; Yeom M; Moon B; Huang XP; Roth BL; Lee K; Rhim H; Choo IH; Chong Y; Keum G; Nam G; Choo H
    ChemMedChem; 2013 Nov; 8(11):1855-64. PubMed ID: 24039134
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rational design in search for 5-phenylhydantoin selective 5-HT7R antagonists. Molecular modeling, synthesis and biological evaluation.
    Kucwaj-Brysz K; Warszycki D; Podlewska S; Witek J; Witek K; González Izquierdo A; Satała G; Loza MI; Lubelska A; Latacz G; Bojarski AJ; Castro M; Kieć-Kononowicz K; Handzlik J
    Eur J Med Chem; 2016 Apr; 112():258-269. PubMed ID: 26900658
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulatory effects following subchronic stimulation of brain 5-HT7-R system in mice and rats.
    Romano E; Ruocco LA; Nativio P; Lacivita E; Ajmone-Cat MA; Boatto G; Nieddu M; Tino A; Sadile AG; Minghetti L; Passarelli F; Leopoldo M; Laviola G; Adriani W
    Rev Neurosci; 2014; 25(3):383-400. PubMed ID: 24598832
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stimulation of 5-HT7 receptor during adolescence determines its persistent upregulation in adult rat forebrain areas.
    Nativio P; Zoratto F; Romano E; Lacivita E; Leopoldo M; Pascale E; Passarelli F; Laviola G; Adriani W
    Synapse; 2015 Nov; 69(11):533-42. PubMed ID: 26364910
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New arylpiperazinylalkyl derivatives of 8-alkoxy-purine-2,6-dione and dihydro[1,3]oxazolo[2,3-f]purinedione targeting the serotonin 5-HT1A /5-HT2A /5-HT7 and dopamine D2 receptors.
    Chłoń-Rzepa G; Zagórska A; Bucki A; Kołaczkowski M; Pawłowski M; Satała G; Bojarski AJ; Partyka A; Wesołowska A; Pękala E; Słoczyńska K
    Arch Pharm (Weinheim); 2015 Apr; 348(4):242-53. PubMed ID: 25773907
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 5-HT1A-versus D2-receptor selectivity of flesinoxan and analogous N4-substituted N1-arylpiperazines.
    Kuipers W; Kruse CG; van Wijngaarden I; Standaar PJ; Tulp MT; Veldman N; Spek AL; IJzerman AP
    J Med Chem; 1997 Jan; 40(3):300-12. PubMed ID: 9022796
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Investigations on the 1-(2-biphenyl)piperazine motif: identification of new potent and selective ligands for the serotonin(7) (5-HT(7)) receptor with agonist or antagonist action in vitro or ex vivo.
    Lacivita E; Patarnello D; Stroth N; Caroli A; Niso M; Contino M; De Giorgio P; Di Pilato P; Colabufo NA; Berardi F; Perrone R; Svenningsson P; Hedlund PB; Leopoldo M
    J Med Chem; 2012 Jul; 55(14):6375-80. PubMed ID: 22738316
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.